Fresh IPO Signals: Director Buys PBLS Stock—What It Means
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesA Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
Tesla has fallen about 14% this year, but a dip isn’t a doom signal. Here’s a clear framework to decide if now is the...
Bloom Energy faces a bearish price prediction as momentum cools and AI-driven demand faces headwinds, suggesting sign...
Public disclosures show intriguing shifts in a high-profile portfolio. This article breaks down what it means when pr...
Credo Technology rides a surge in AI infrastructure demand, but the path to $500 by 2030 hinges on durable revenue gr...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
As 2026 unfolds, investors must weigh software-driven growth against hardware resilience. This guide compares Salesfo...
Apple is reportedly adopting a Netflix style strategy, focusing on originals, bundling, and scalable growth. This art...
Nvidia’s upcoming earnings have many traders eyeing the odds. Prediction markets are whispering a high probability of...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...